In April, the American Society of Health-System Pharmacists reported 323 ongoing drug shortages — the highest number since the organization began tracking them in 2001. The number has since fallen to 277.
Connecticut has told Los Angeles-based Prospect Medical Holdings that it wants monitors on board at its three state hospitals amid ongoing disputes with Yale New Haven (Conn.) Health over a $435 million stalled deal for the facilities.
A recent investigation by The New York Times revealed that two pharmaceutical companies, Eisai and Eli Lilly, withheld critical genetic risk information from volunteers during clinical trials for Alzheimer’s drugs, Leqembi and Kisunla.
More than 7,000 bottles of duloxetine, a generic version of antidepressant Cymbalta, have been recalled by the FDA due to the presence of N-nitroso-duloxetine, a chemical that is a suspected carcinogen.
The University of Texas MD Anderson Cancer Center will begin construction on its $239.2 million biosciences research facility Oct. 28, Chron reported Oct. 23.
Manhasset, N.Y.-based North Shore University Hospital had the lowest 30-day mortality rate for coronary artery bypass graft patients in the U.S. between July 1, 2020, and June 30, 2023, according to CMS data released July 31.
As hospitals become increasingly interconnected, cybersecurity challenges are evolving rapidly, that’s why New York City-based Montefiore Health System’s CIO is looking at other industries for cyber strategy.
Minneapolis-based Allina Health, a 12-hospital system, has notified about 18,000 patients with Humana Medicare Advantage plans that their clinicians will be out-of-network in 2025 unless the payer agrees to a contract that reduces prior authorization h…